Banking

Stocks With Rising Composite Ratings: qvia Holdings

qvia Holdings (IQV) saw its IBD SmartSelect Composite Rating rise to 98 Friday, up from 92 the day before.




X



The upgrade means the stock is now outperforming 98% of all other stocks in terms of key performance metrics and technical strength. The market’s biggest winners often have a 95 or higher rating in the early stages of a new price run, so that’s an important benchmark to look for when looking for the best stocks to buy and watch.

qvia Holdings is currently extended beyond a proper buy zone after breaking out from a 200.09 entry in a flat base.


See How IBD Helps You Make More Money In Stocks


The stock earns a 92 EPS Rating, which means its recent quarterly and longer-term annual earnings growth tops 92% of all stocks.

Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors over the last 13 weeks.

In Q1, the company posted 45% EPS growth. That means it’s now posted three straight quarters of rising EPS growth. Top line growth increased 24%, up from 14% in the prior report. That marks three quarters of increasing revenue gains.

qvia Holdings earns the No. 1 rank among its peers in the Medical-Research Equipment/Services industry group. Bio-Techne (TECH) and Charles River Labs International (CRL) are also among the group’s highest-rated stocks.

YOU MIGHT ALSO LIKE:

Which Companies Are Now Outperforming 95% Of All Stocks?

See Which Stocks Just Came On — And Off — IBD’s Top Stock Lists

Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup

Most Related Links :
newsbinding Governmental News Finance News

Source link

Back to top button